Overview

A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001

Status:
Withdrawn
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
MP-101 will be evaluated in this study to see if it is safe and tolerable.
Phase:
Phase 3
Details
Lead Sponsor:
Marathon Pharmaceuticals, LLC
Treatments:
Opium